High-content high-throughput assays for characterizing the viability and morphology of human iPSC-derived neuronal cultures

Assay and Drug Development Technologies

Volumn 12, Issue 9-10, 2014, Pages 536-547

  Sirenko, Oksana ^a   Hesley, Jayne ^a   Rusyn, Ivan ^b   Cromwell, Evan F ^a  

^a MOLECULAR DEVICES CORPORATION   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA III TUBULIN; BETA TUBULIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; MICROTUBULE ASSOCIATED PROTEIN 2; MITOMYCIN; RAPAMYCIN; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BRAIN MITOCHONDRION; CALCEIN-AM ASSAY; CELL ASSAY; CELL COUNT; CELL FUNCTION; CELL MEMBRANE POTENTIAL; CELL STRUCTURE; CELL VIABILITY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL CULTURE; NERVE CELL NETWORK; NERVE FIBER GROWTH; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PLURIPOTENT STEM CELL; QUANTITATIVE ANALYSIS; CELL SURVIVAL; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; NERVE CELL; PHYSIOLOGY; PROCEDURES;

CELL CULTURE TECHNIQUES; CELL SURVIVAL; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURONS;

EID: 84918567172     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2014.592     Document Type: Article

References (41)

1. May M: Disturbing behavior: neurtotoxic effects in children. Environ Health Perspect 2000;108:A262-A267.
2. Chang LW: Principles of Neurotoxicology. M. Dekker, New York, NY, 1994.
3. Travis LB, Fossa SD, Sesso HD, et al.: Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics. J Natl Cancer Inst 2014;106:dju044.
4. Kola I, Landis J: Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004;3:711-715.
5. Hartung T: Toxicology for the twenty-first century. Nature 2009;460:208-212.
6. Bal-Price AK, Hogberg HT, Buzanska L, Coecke S: Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered. Neurotoxicol Teratol 2010;32:36-41.
7. Harrill JA, Freudenrich TM, Machacek DW, Stice SL, Mundy WR: Quantitative assessment of neurite outgrowth in human embryonic stem cell-derived hN2 cells using automated high-content image analysis. Neurotoxicology 2010;31:277-290.
8. Gotte M, Hofmann G, Michou-Gallani AI, Glickman JF, Wishart W, Gabriel D: An imaging assay to analyze primary neurons for cellular neurotoxicity. J Neurosci Methods 2010;192:7-16.
9. Al-Ali H, Schurer SC, Lemmon VP, Bixby JL: Chemical interrogation of the neuronal kinome using a primary cell-based screening assay. ACS Chem Biol 2013;8:1027-1036.
10. Radio NM, Mundy WR: Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 2008;29:361-376.
11. Radio NM, Breier JM, Shafer TJ, Mundy WR: Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening. Toxicol Sci 2008;105:106-118.
12. Breier JM, Radio NM, Mundy WR, Shafer TJ: Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicol Sci 2008;105:119-133.
13. Young A, Machacek DW, Dhara SK, et al.: Ion channels and ionotropic receptors in human embryonic stem cell derived neural progenitors. Neuroscience 2011;192:793-805.
14. Dragunow M: High-content analysis in neuroscience. Nat Rev Neurosci 2008;9:779-788.
15. Harrill JA, Robinette BL, Freudenrich T, Mundy WR: Use of high content image analyses to detect chemical-mediated effects on neurite sub-populations in primary rat cortical neurons. Neurotoxicology 2013;34:61-73.
16. Efthymiou A, Shaltouki A, Steiner JP, et al.: Functional screening assays with neurons generated from pluripotent stem cell-derived neural stem cells. J Biomol Screen 2014;19:32-43.
17. Chen G, Gulbranson DR, Hou Z, et al.: Chemically defined conditions for human iPSC derivation and culture. Nat Methods 2011;8:424-429.
18. Hu BY, Weick JP, Yu J, et al.: Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A 2010;107:4335-4340.
19. Anson BD, Kolaja KL, Kamp TJ: Opportunities for use of human iPS cells in predictive toxicology. Clin Pharmacol Ther 2011;89:754-758.
20. Haythornthwaite A, Stoelzle S, Hasler A, et al.: Characterizing human ion channels in induced pluripotent stem cell-derived neurons. J Biomol Screen 2012;17:1264-1272.
21. Chai X, Dage JL, Citron M: Constitutive secretion of tau protein by an unconventional mechanism. Neurobiol Dis 2012;48:356-366.
22. Whitemarsh RC, Strathman MJ, Chase LG, et al.: Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection. Toxicol Sci 2012;126:426-435.
23. Dage JL, Colvin EM, Fouillet A, et al.: Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons. Psychopharmacology 2014;231:1105-1124.
24. Guo L, Abrams RM, Babiarz JE, et al.: Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci 2011;123:281-289.
25. Sirenko O, Hesley J, Rusyn I, Cromwell EF: High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells. Assay Drug Dev Technol 2014;12:43-54.
26. Xu X, Lei Y, Luo J, et al.: Prevention of beta-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle events. Stem Cell Res 2013;10:213-227.
27. Hu K, Yu J, Suknuntha K, et al.: Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 2011;117:e109-e119.
28. Katsetos CD, Herman MM, Mork SJ: Class III beta-tubulin in human development and cancer. Cell Motil Cytoskeleton 2003;55:77-96.
29. Neve RL, Harris P, Kosik KS, Kurnit DM, Donlon TA: Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res 1986;387:271-280.
30. Lammer EJ, Chen DT, Hoar RM, et al.: Retinoic acid embryopathy. N Engl J Med 1985;313:837-841.
31. Clarkson TW, Magos L, Myers GJ: The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med 2003;349:1731-1737.
32. Swarnkar S, Singh S, Sharma S, Mathur R, Patro IK, Nath C: Rotenone induced neurotoxicity in rat brain areas: a histopathological study. Neurosci Lett 2011;501:123-127.
33. Gao HM, Hong JS, Zhang W, Liu B: Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 2002;22:782-790.
34. Baker LH, Opipari MI, Wilson H, Bottomley R, Coltman CA, Jr. Mitomycin C, vincristine, and bleomycin therapy for advanced cervical cancer. Obstet Gynecol 1978;52:146-150.
35. Reers M, Smiley ST, Mottola-Hartshorn C, Chen A, Lin M, Chen LB. Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 1995;260:406-417.
36. Forgacs B, Merhav HJ, Lappin J, Mieles L: Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Transplant Proc 2005;37:1912-1914.
37. McNeish J, Roach M, Hambor J, et al.: High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors. J Biol Chem 2010;285:17209-17217.
38. Breier JM, Gassmann K, Kayser R, et al.: Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. Neurotoxicol Teratol 2010;32:4-15.
39. Emmrich JV, Hornik TC, Neher JJ, Brown GC: Rotenone induces neuronal death by microglial phagocytosis of neurons. FEBS J 2013;280:5030-5038.
40. Kunimoto M: Methylmercury induces apoptosis of rat cerebellar neurons in primary culture. Biochem Biophys Res Commun 1994;204:310-317.
41. Zhang H, Dougherty PM: Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy. Anesthesiology 2014;120:1463-1475.